These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Experience with tromexan]. GARCIA TUIRELLA R; BRUERA EF; DE ROSA J Prensa Med Argent; 1952 May; 39(21):1135-42. PubMed ID: 14948838 [No Abstract] [Full Text] [Related]
4. [Resorption of arterial embolus by tromexan]. CID DOS SANTOS Mem Acad Chir (Paris); 1952 Apr; 78(12-13):361-2. PubMed ID: 14947580 [No Abstract] [Full Text] [Related]
5. Clinical experience with the anticoagulant, tromexan. BRONSTEIN MR; WITKIND E Am J Med Sci; 1951 Dec; 222(6):677-85. PubMed ID: 14885211 [No Abstract] [Full Text] [Related]
6. [Tromexan in the treatment of thrombosis and embolism in urology]. OBE G; LANG H; ALCALA F Med Esp; 1952 Mar; 27(156):178-84. PubMed ID: 14940390 [No Abstract] [Full Text] [Related]
7. Tromexan in the treatment of coronary thrombosis. TULLOCH JA; GILCHRIST AR Am Heart J; 1951 Dec; 42(6):864-75. PubMed ID: 14885082 [No Abstract] [Full Text] [Related]
8. [Possibility of tromexan therapy of anterior chamber inflammations of the eye]. ZWIAUER A Wien Klin Wochenschr; 1951 Sep; 63(35-36):697-8. PubMed ID: 14877189 [No Abstract] [Full Text] [Related]
9. [Control of anticoagulant therapy by derivatives of coumarine (dicumarol and tromexan)]. PUNDEL JP Sem Med; 1952 Mar; 28(10):199-203. PubMed ID: 14942529 [No Abstract] [Full Text] [Related]
10. [Prevention of thrombosis with tromexan in puerperium]. MERZ WR; CHRIST MA Schweiz Med Wochenschr; 1952 Feb; 82(8):196-7. PubMed ID: 14930727 [No Abstract] [Full Text] [Related]
11. [Use of anticoagulants in dermatology; use of tromexan (ethyl ester of di-4-hydroxy-coumarinyl acetic acid) in ulcus cruris in dystrophy with thrombophlebitis and in related conditions]. PANCONESI E Rass Dermatol Sifilogr; 1951; 4(2):74-105. PubMed ID: 14892261 [No Abstract] [Full Text] [Related]
12. Clinical evaluation of ethyl biscoumacetate (tromexan). VANDER VEER JB; FUNK EH; BOYER FR; KELLER EA Am J Med; 1953 Jun; 14(6):694-703. PubMed ID: 13057879 [No Abstract] [Full Text] [Related]
13. Ethyl biscoumacetate (tromexan) in coronary artery disease. POLLITZER RS J S C Med Assoc; 1953 Mar; 49(3):66-8. PubMed ID: 13045283 [No Abstract] [Full Text] [Related]
14. The physiological disposition of ethyl biscoumacetate (tromexan) in man and a method for its estimation in biological material. BRODIE BB; WEINER M; BURNS JJ; SIMSON G; YALE EK J Pharmacol Exp Ther; 1952 Dec; 106(4):453-63. PubMed ID: 13023556 [No Abstract] [Full Text] [Related]
15. The biotransformation of ethyl biscoumacetate (tromexan) in man, rabbit and dog. BURNS JJ; WEINER M; SIMSON G; BRODIE BB J Pharmacol Exp Ther; 1953 May; 108(1):33-41. PubMed ID: 13053419 [No Abstract] [Full Text] [Related]
16. [Mechanism of action of tromexan]. COSTANTINI A; TINTORI M Boll Soc Ital Biol Sper; 1951 Dec; 27(12):1652-5. PubMed ID: 14934908 [No Abstract] [Full Text] [Related]
17. A study on the toxicology and anticoagulant action of tromexan, a synthetic coumarin. GRUBER CM; LEE KS; LASZICZENKO T; GRUBER CM Arch Int Pharmacodyn Ther; 1951 Sep; 87(4):402-12. PubMed ID: 14895202 [No Abstract] [Full Text] [Related]
18. [Advantages of a new coumarin derivative]. MAGNANI B G Clin Med; 1951 Feb; 32(2):236-7. PubMed ID: 14823373 [No Abstract] [Full Text] [Related]